Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery.
about
Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient management.Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells.Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinomaPrognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal AdenocarcinomaEx Vivo Culture of CTCs: An Emerging Resource to Guide Cancer TherapyA Hybrid One-Way ANOVA Approach for the Robust and Efficient Estimation of Differential Gene Expression with Multiple Patterns.PROGgene: gene expression based survival analysis web application for multiple cancers.Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Recent advances in the molecular characterization of circulating tumor cells.HOXA10 promotes cell invasion and MMP-3 expression via TGFβ2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells.Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.A 25-gene classifier predicts overall survival in resectable pancreatic cancer.Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma.A Speculative Role for Stromal Gastrin Signaling in Development and Dissemination of Pancreatic Ductal AdenocarcinomaCo-dependency between KRAS addiction and ARHGEF2 promotes an adaptive escape from MAPK pathway inhibition.Cancer. Fusion for moving.
P2860
Q30815483-66786D78-4E32-4421-8B5B-777153549A9CQ31171102-BC4F93B2-86DD-4AD0-BD2D-AE55946A8C5EQ34246014-DD1D7E36-C1B0-48CF-AED2-8E1B0A09CDFEQ35738659-8B8AD404-941E-4F8E-A918-23FC60C03DC4Q35752053-A5551D9F-5515-4F92-AE56-F68D89DB3214Q35790288-25706775-6018-4CF4-B3CD-C4B71227BCF1Q37420447-71CD75A8-984A-4496-B34C-6A78795E01FCQ37593966-67B22ED5-B3E7-46F6-816E-F7C4C13E6C3DQ37610799-C49B3002-6935-43C9-BCB4-11458EAEB8A1Q37693504-1CA5CE83-A301-4415-B867-251029853928Q39030544-A5BAFCF2-DFB4-4E9E-9894-594C420DAED9Q41592795-AE9F3AF9-2650-4C0E-AF57-BE794AEF0BB9Q41711884-5990AC75-FA1A-4316-A720-552CC9A7C099Q41861080-FDBF12ED-3DA3-4682-8008-C0FEE40A9E27Q41902545-BDE1F9AE-8140-4644-824E-754315D4B9B1Q48212640-62022A41-34B5-4BEB-9D24-EBE172280F5DQ48887336-7F9E3D97-1EE5-49D1-9557-5099304ED7E9
P2860
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pancreatic cancer circulating ...... edicts survival after surgery.
@ast
Pancreatic cancer circulating ...... edicts survival after surgery.
@en
type
label
Pancreatic cancer circulating ...... edicts survival after surgery.
@ast
Pancreatic cancer circulating ...... edicts survival after surgery.
@en
prefLabel
Pancreatic cancer circulating ...... edicts survival after surgery.
@ast
Pancreatic cancer circulating ...... edicts survival after surgery.
@en
P2093
P2860
P356
P1433
P1476
Pancreatic cancer circulating ...... edicts survival after surgery.
@en
P2093
Baki Topal
Gregory Sergeant
Rudy van Eijsden
Victor Van Duppen
P2860
P2888
P356
10.1186/1471-2407-12-527
P407
P577
2012-11-16T00:00:00Z
P5875
P6179
1002024395